The world is running out of useful antibiotics. Over the past decades, pan-resistant strains of major bacterial pathogens have emerged that have rendered clinically available antibiotics ineffective. As a consequence, many of the major achievements of modern medicine are now at risk. With the pipeline of new antimicrobials slowing to a standstill, alternative strategies are required to identify clinically useful antimicrobials.
In Switzerland and the Basel Area in particular, world-leading scientists work in the life sciences, with important industrial companies at the cutting-edge of antibiotic R&D. Our symposium and networking event aims to promote the full potential of synergies between different stakeholders and to increase collaboration between experts in different research-fields who might be able to contribute to antibiotics R&D. The symposium will highlight technologies and approaches that are presently underexploited but that could prove crucial in supporting antibiotic research, ranging from single-cell analysis to exploration of microbial behavior within tissue sites.
The aim of this event is to connect key players in antibiotic-research to discuss present roadblocks to understanding antibiotic action, discovery and development, as well as to discuss how new technologies could help to overcome some of the challenges in the field.
Who should attend?
The symposium aims at an interdisciplinary audience working on antibiotics R&D in industry or academia, as well as at anyone interested in contributing to the field, including biologists, biomedical engineers, chemists and clinicians.
Please join us at this event on April 26th 2018, 17:00 to 19:30, at SUD, Burgweg 7, 4058 Basel.